C07D 519/00
Heterocyclic compounds containing more than one system of two or more relevant
Official title: Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
C07D519/00 (Heterocyclic compounds containing more than one system of two or more relevant) appears on 5,064 US grants and 7,826 published applications in this corpus.
Search patents in C07D- Granted patents
- 5,064
- Published applications
- 7,826
- Assignees
- 2,077
- Inventors
- 18,295
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 9 | 0 |
| 1977 | 7 | 0 |
| 1978 | 14 | 0 |
| 1979 | 9 | 0 |
| 1980 | 16 | 0 |
| 1981 | 12 | 0 |
| 1982 | 8 | 0 |
| 1983 | 8 | 0 |
| 1984 | 6 | 0 |
| 1985 | 14 | 0 |
| 1986 | 7 | 0 |
| 1987 | 17 | 0 |
| 1988 | 18 | 0 |
| 1989 | 22 | 0 |
| 1990 | 25 | 0 |
| 1991 | 20 | 0 |
| 1992 | 16 | 0 |
| 1993 | 21 | 0 |
| 1994 | 13 | 0 |
| 1995 | 10 | 0 |
| 1996 | 10 | 0 |
| 1997 | 11 | 0 |
| 1998 | 14 | 0 |
| 1999 | 11 | 0 |
| 2000 | 18 | 0 |
| 2001 | 15 | 3 |
| 2002 | 14 | 14 |
| 2003 | 13 | 19 |
| 2004 | 12 | 42 |
| 2005 | 14 | 55 |
| 2006 | 24 | 44 |
| 2007 | 34 | 73 |
| 2008 | 31 | 115 |
| 2009 | 55 | 123 |
| 2010 | 62 | 151 |
| 2011 | 79 | 193 |
| 2012 | 107 | 195 |
| 2013 | 164 | 230 |
| 2014 | 211 | 299 |
| 2015 | 255 | 353 |
| 2016 | 281 | 398 |
| 2017 | 347 | 391 |
| 2018 | 328 | 445 |
| 2019 | 367 | 433 |
| 2020 | 311 | 456 |
| 2021 | 325 | 492 |
| 2022 | 309 | 544 |
| 2023 | 318 | 784 |
| 2024 | 337 | 739 |
| 2025 | 431 | 714 |
| 2026 | 284 | 521 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Sirt6 activators6 Oct 2026US 12,753,180 B2Board of Regents, The University of Texas System
- 2-aminopyrimidine compound and pharmaceutical composition thereof and application thereof6 Oct 2026US 12,753,185 B2Guangzhou Salustier Biosciences Co., Ltd.
- Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesviruses6 Oct 2026US 12,753,187 B2Merck Sharp & Dohme Corp.
- Azaheteroaryl compound, preparation method therefor, and application thereof6 Oct 2026US 12,753,189 B2Shanghai Aolu Biomedical Technology Co., Ltd.
- Spirotricycle RIPK1 inhibitors and methods of uses thereof6 Oct 2026US 12,753,190 B2Merck Sharp & Dohme Corp.
- Pyrido[4,3-d]pyrimidine compounds8 Oct 2026US 2026/0306506 A1Pfizer Inc.
- Pyrazolotriazinecarbonitriles useful as kinase inhibitors8 Oct 2026US 2026/0308156 A1Bristol-Myers Squibb Company
- Bicyclic heteroarylamides having gpr68 modulating activity8 Oct 2026US 2026/0308159 A1Recursion Pharmaceuticals, Inc.
- Chimeric compounds useful in treating diseases8 Oct 2026US 2026/0308161 A1
- Anthelmintic aza-benzothiophene and aza-benzofuran compounds8 Oct 2026US 2026/0308170 A1Boehringer Ingelheim Vetmedica GmbH
Most cited
By later US patents
- Compound for use in organic electroluminescent device and organic electroluminescent device195US 7,993,760 B2Nippon Steel Chemical Co., Ltd. · 2011
- Drugs comprising porphyrins188US 4,649,151 AHealth Research, Inc. · 1987
- Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase186US 7,718,662 B1Pharmacyclics, Inc. · 2010
- Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase153US 7,741,330 B1Pharmacyclics, Inc. · 2010
- Methods for treatment of tumors149US 4,932,934 AHealth Research, Inc. · 1990